Investor Relations

A Vertically Integrated Medical Cannabis Company

Columbia Care is a vertically integrated medical cannabis company with a U.S. license portfolio* that allows for up to 730K square feet of cultivation and the potential to produce more than 125 K kilograms of dried flower per year.

TGS Acquisition

View Presentation

Columbia Care Welcomes Frank Savage and Jeff Clarke as New Independent Directors to Its Board

View Press Release View All

Jan 6, 2020 • 9:05 AM EST

Columbia Care Has Triple-Digit Growth After Launch of Adult Use Sales in Illinois and Announces Partnerships with Local Social Equity Groups

Jan 6, 2020 • 9:00 AM EST

Columbia Care Selected by the Utah Department of Health to Receive One of 14 Medical Cannabis Pharmacy Licenses

Dec 12, 2019 • 4:34 PM EST

Columbia Care Announces Execution of Definitive Agreement for Sale-Leaseback with NewLake Capital Increasing Liquidity By $35 Million

Investor Presentation

View Presentation

Feb 19 – Feb 20, 2020

NCIA Northeast Cannabis Business Conference

Feb 24 – Feb 25, 2020

Benzinga Cannabis Capital Conference

View All

Jan 14, 2020

AltaCorp Capital: 8th Annual Institutional Investor Conference

Dec 11 – Dec 13, 2019

MJBizCon

View All

Stock Snapshot

Columbia Care at a Glance

Licenses in 17 jurisdictions across
U.S. and E.U.
(includes industrial hemp cultivation)

Facilities that are operational or in development.

>1.4M

Sales transactions to date

As of Feb, 2, 2020 • ColCare Mgt Presentation

Setting the Standard for Compassion and Quality

Columbia Care Inc. (“Columbia Care” or the “Company”) is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1.4 million successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.

View Management Team View Board of Directors

~60% CAGR

~74% CAGR

Pharmaceutical Quality Products

Our balanced portfolio of proprietary, precisely-formulated and precision dosed pharmaceutical-quality medical, health, wellness and consumer branded products include hard-pressed tablets, vapes, tinctures, suppositories and topicals to address the needs of every market.

Research and Development

In order to further our strategic insight and innovation, we develop strategic relationships with clinical and scientific organizations (such as Mount Sinai Hospital), agricultural and manufacturing organizations (such as the Pennsylvania Department of Agriculture), and organizations with a technological advantage (such as Arizona State University).

IR Contacts

Company

Columbia Care Inc.
745 5th Avenue
Suite 1701
New York, NY 10151
T: 212-634-7100
info@col-care.com